Topic: Public Policy
How Far Would You Go for an Ivy League Kid?
Study finds interest in screening embryos for education propensity, especially if everyone else is doing it
Another Political Trick? Inducing Forgetting By Mentioning Irrelevant Information
Positive views on, say, a social policy are more easily suppressed than negative ones
An Enemy’s Economic Success Sparked U.S. Congressional Cooperation
Bipartisan action rose amid reports of surprising Soviet Cold War economic growth
Kids Who Moved from Public Housing More Likely to Vote as Adults
Demolition of Chicago projects dispersed thousands to other areas
In U.S.-China Trade War, Bystander Countries Increase Exports
Higher demand from U.S. and China means expanding into new markets
Experts Struggle to Accurately Forecast Societal Change
On COVID-19’s impacts, social scientists’ predictions weren’t much better than those of laypeople
The Transformative Potential of Financial Reparations
Payouts to victims of Colombia’s decadeslong armed conflict suggest benefits may exceed the initial cost
A Nudge to Reduce the Government Tab for Nursing Home Care
An upfront fee for taking Medicaid patients could shorten stays
Smartphone Records Reveal Racial Disparities in Neighborhood Policing
Police patrol Black areas more frequently than others with similar homicide rates and income levels
Do Workers Cross State Lines for Higher Minimum Wages?
States that raise rates curtail out-migration but do not attract more outsiders
Why Big Banks Can Pay Less on Deposits
Their level of technology and services makes up for it; it’s vice versa with little banks
Populism’s Rise in U.S. Isn’t Only About Anger
2016 vote shares for Trump and Sanders point to a mix of negative emotions
Why Do Banks With Little Skin in the Game Still Monitor Borrowers?
Tax policy change triggers an incentive for lenders to be more aggressive
Historical Case for Immigrants Sending Home More Than Money
France’s lower fertility rates spread to regions that sent the most emigrants to live there
When Medicare Pays, Drug Companies Employ Older Subjects in Clinical Trials
The shift lends credibility to medicines vs. trials that exclude people 65 and older